Improving the feasibility of deprescribing proton pump inhibitors: GPs’ insights on barriers, facilitators, and strategies

Improving the feasibility of deprescribing proton pump inhibitors: GPs’ insights on barriers, facilitators, and strategies

IntroductionThe prevalent overprescribing of proton pump inhibitors (PPIs) poses health risks from prolonged use. GPs play a key role in initiating deprescribing PPIs, so understanding their decision-making factors and strategies to improve feasibility is crucial. This study aimed to investigate the...

Full description

Bibliographic Details
Main Authors: Nuša Japelj, Lea Knez, Davorina Petek, Nejc Horvat
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-09-01
Series:Frontiers in Pharmacology
Subjects:
deprescriptions
primary healthcare
proton pump inhibitors
inappropriate prescribing
qualitative research
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1468750/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1468750/full

Similar Items